To ask the Secretary of State for Health and Social Care, with reference to paragraph 16 of Annex B of the Impact Assessment for the Statutory Scheme – Branded Medicines Pricing, what the evidential basis is for the assessment that the resources deployed 
The approach to assessing the potential impacts on investment within the statutory scheme’s impact assessment followed well established precedent and is in-line with the Green Book paragraphs 6.5 and 6.6. As such the impact assessment considers spill-over...
NHS: Drugs